Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet in parathyroid carcinoma or intractable primary hyperparathyroidism
NCT00037518Phase 4Completed
- Sponsor
- Amgen
- Start
- Apr 2001
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of cinacalcet in parathyroid carcinoma, primary hyperparathyroidism (PHPT), sponsored by Amgen. Started Apr 2001; status: completed.
02
Drugs
cinacalcet
03
Conditions
parathyroid carcinomaprimary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on NCT00037518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00037518.